HistoCyte – Lung Cancer controls

Gaining over 15,000 cases this 2024 and leading with the lowest survival rate for cancer types, lung cancer has been in the forefront of cancer cases in Australia. Biomarkers such ALK, ROS1, PD-L1, and BRAF are used in IHC and molecular laboratory techniques to identify specific types of lung cancer and guide targeted therapy.

HistoCyte – ER/PR/HER2/PDL1 controls

HistoCyte tissue controls are a testament to precision and reliability in the diagnosis of breast cancer.

New HistoCyte ALK DR

Products are for professional/laboratory use only. The ALK Dynamic Range product allows the user to determine if the ALK assay being used is sensitive enough for the use in the detection of EML4-ALK, NPM-ALK, or both.